Drug name - Zmax

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6984403 PF PRISM CV Azithromycin dosage forms with reduced side effects Feb, 2024

(1 year, 4 months from now)

US7887844 PF PRISM CV Multiparticulate crystalline drug compositions having controlled release profiles Feb, 2024

(1 year, 4 months from now)

Drugs and Companies using AZITHROMYCIN ingredient

Treatment: Method of treating bacterial infections

Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 2GM BASE/BOT FOR SUSPENSION, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.